Determination of olanzapine and desmethylolanzapine in the plasma of schizophrenic patients by means of an improved HPLC method with amperometric detection

[1]  M. Raggi,et al.  A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction procedure. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[2]  E. Kenndler,et al.  Quantitation of olanzapine in tablets by HPLC, CZE, derivative spectrometry and linear voltammetry. , 2000, Journal of pharmaceutical and biomedical analysis.

[3]  S. Fanali,et al.  Determination of the novel antipsychotic drug olanzapine in human plasma using HPLC with amperometric detection , 2000 .

[4]  C. Beasley,et al.  Olanzapine. Pharmacokinetic and pharmacodynamic profile. , 1999, Clinical pharmacokinetics.

[5]  R. Erkwoh,et al.  Monitoring of olanzapine in serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[6]  J. T. Johnson,et al.  Determination of olanzapine in human breast milk by high-performance liquid chromatography with electrochemical detection. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[7]  A. Jenkins,et al.  Determination of olanzapine in a postmortem case. , 1998, Journal of analytical toxicology.

[8]  M. Berna,et al.  Determination of olanzapine in human plasma and serum by liquid chromatography/tandem mass spectrometry. , 1998, Journal of mass spectrometry : JMS.

[9]  O. Olesen,et al.  Determination of olanzapine in serum by high-performance liquid chromatography using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[10]  S. Marder,et al.  Plasma level monitoring of olanzapine in patients with schizophrenia: determination by high-performance liquid chromatography with electrochemical detection. , 1997, Therapeutic drug monitoring.

[11]  K. Goa,et al.  Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. , 1997, Drugs.

[12]  J. Chiu,et al.  Analysis and pharmacokinetics of olanzapine (LY170053) and two metabolites in rat plasma using reversed-phase HPLC with electrochemical detection. , 1996, Journal of pharmaceutical and biomedical analysis.

[13]  B. Ring,et al.  Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine. , 1996, The Journal of pharmacology and experimental therapeutics.

[14]  T. Gillespie,et al.  Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection. , 1995, Journal of chromatography. B, Biomedical applications.